ADNTRO has been awarded as one of Europe's Top 10 Genomic Solutions providers in 2022 05/09/2022 Personalized medicine ADNTRO has been awarded as one of Europe's Top 10 Genomic Solutions providers in 2022, for standing out with its... Partners - ADNTRO GENETICS SL
Life Length obtains European authorization for its innovative prostate cancer diagnostic ... 09/06/2022 PROSTAV® tiene por objeto mejorar sustancialmente el diagnóstico de cáncer de próstata; el más frecuente en los hombres... Partners
Peaches Biotech publishes positive “in vivo” results of its drug PRS CK STORM 18/05/2022 Healthcare Innovative drugs Personalized medicine Advanced therapies The results show the high efficacy and safety of PRS CK STORM as a medicine to prevent and treat the cytokine storm... Partners - PEACHES BIOTECH S.L.
Peaches Biotech publishes positive “in vivo” results of its drug PRS CK STORM against the ... 11/05/2022 Healthcare Personalized medicine Advanced therapies The results show the high efficacy and safety of PRS CK STORM as a medicine to prevent and treat the cytokine storm... Partners - PEACHES BIOTECH S.L.
PharmaBoardoom points out VIVEbiotech as one of the ten Spanish Biotechs to watch in 2022 21/04/2022 Rare diseases Innovative drugs Personalized medicine Advanced therapies PharmaBoardroom, a leading British media specialized in the health sector, has published an article in which it... Partners - VIVEbiotech
Venture capital plays key role in fight against cancer 29/03/2022 Healthcare Drug discovery Innovative drugs Personalized medicine Advanced therapies Financing On 28 April, AseBio Investor Day will bring together more than 50 investors from all over the world with disruptive... AseBio
BIOJAPAN 2022 Yokohama and On-line Japan Del 12/10/2022 to 14/10/2022 Healthcare Access to innovation Personalized medicine
Dámaso Molero, CEO of 3P Biopharmaceuticals, appointed member of the Technical Committee o... 04/03/2022 Personalized medicine Navarra advances in the Comprehensive Strategy for Personalized Medicine with the constitution of the body that will... Partners - 3PBIOVIAN
Report | The incredible challenge of diagnosing a silent disease: Alzheimer's 21/09/2021 Healthcare In vitro diagnostics Personalized medicine To mark World Alzheimer's Day, we spoke to Marta Barrachina, founder and CEO of ADmit Therapeutics, one of our partners... AseBio - ADmit Therapeutics
Personalised medicine increases its activity by 40% in the last year and is becoming more ... 14/07/2021 Precision medicine and personalised medicine products or services have gone from representing 12% of total launches to... AseBio
